Clene (CLNNW) Stock Price, News & Analysis
Company Description
Clene (NASDAQ: CLNNW) is classified in the Pharmaceutical Preparations sector.
CLNNW has declined 96.4% over the past year. Shares last traded at $0.0018.
On a trailing twelve-month basis, Clene reported revenue of $200K with net income of -$26.2M. The company operates at a net profit margin of -13086.5%.
This page collects what Stock Titan holds for CLNNW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Clene (CLNNW) stock last traded at $0.0018. Over the past 12 months, the stock has lost 96.4%.
CLNNW Rankings
Latest News
SEC Filings
Clene has filed 5 recent SEC filings, including 4 Form 4, 1 Form 8-K. The most recent filing was submitted on May 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLNNW SEC filings →
Financial Highlights
Clene generated $200K in revenue over the trailing twelve months, retaining a 78.5% gross margin, operating income reached -$23.1M (-11541.5% operating margin), and net income was -$26.2M, reflecting a -13086.5% net profit margin. The company generated -$18.5M in operating cash flow. With a current ratio of 0.83, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Clene (CLNNW) currently stands at 3.2 thousand shares, up 39.3% from the previous reporting period. Over the past 12 months, short interest has increased by 279.2%.
Days to Cover History
Days to cover for Clene (CLNNW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CLNNW Company Profile & Sector Positioning
Clene (CLNNW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.